1、Recommended indications
2、Can liraglutide be used to lose weight in China?
Guide: Recently, the National Institute of health and health care excellence (NICE) has updated the guidelines on the use of glp-1ra liraglutide in the national health service of the United Kingdom, with the focus on recommending liraglutide for the treatment of obesity. It also indicates the potential role of these drugs in the prevention of type 2 diabetes.
Recommended indications
The recommended indications of liraglutide published by nice are: for obesity treatment of non-diabetic hyperglycemic adults with body mass index (BMI) ≥ 35kg / m ^ 2 and high cardiovascular risk factors such as hypertension or high cholesterol.
A nice spokesman said: “the Independent Commission has received more clinical evidence that liraglutide plus lifestyle interventions can reduce more weight than lifestyle interventions alone. Liraglutide can also delay the development of type 2 diabetes and cardiovascular disease, which is the main benefit of treatment. According to the practice of obesity specialist service, the treatment period is two years. “
Nice had previously refused to recommend liraglutide for the treatment of obesity, mainly because of the cost of medication: in January this year, the agency released the preliminary conclusions in the evaluation process, saying that the cost-benefit evaluation was “uncertain”, but with the reduction of the cost of medication, nice adjusted its recommendation.
Can liraglutide be used to lose weight in China?
In our country’s drug instructions, although larutide has not been approved for weight loss. However, on July 10, 2020, the latest version of the drug catalogue (2020 Edition) released on the official website of Guangdong Pharmaceutical Association has included the description of liraglutide for the treatment of obesity / overweight: for the treatment of patients with BMI > 25kg / m ^ 2 and at least one obesity complication; or simple obesity patients with BMI > 30kg / m ^ 2.